How Beneficial are Essential Phospholipids in IBD?

Arun Kedia, Managing Director, VAV Lipids

As medical science advances, the mechanisms underlying the interrelation between tight junctions and their anchoring membrane lipid content will be better understood. This also holds for understanding how phospholipids regulate other membranous structures in the healthy intestinal epithelium and during inflammation. Future research should further investigate how a particular phospholipid impacts the pathogenesis of Inflammatory bowel diseases. The effect of the diet on phospholipid metabolism and its relationship with microbiota are potential research areas.

Inflammatory bowel diseases, commonly known as IBD, constitute a diverse group of inflammatory conditions affecting the gastrointestinal tract. IBD can significantly impact an individual’s well-being. A mild case can be managed with medication; however, a severe case may require surgery. If left untreated, it can sometimes even be life-threatening. Ulcerative colitis and Crohn’s disease are the predominant types, and the initial irritable bowel syndrome (IBS) affects a more significant proportion of the Western population. Crohn’s disease impacts the small and large intestines, mouth, oesophagus, stomach, and anus. In contrast, ulcerative colitis predominantly targets the colon and rectum, showcasing superficial mucosal damage. The prevalence of IBD varies geographically, with elevated rates observed in Europe and North America, contrasting with lower rates in Asia. As for India, according to recent research conducted by the IBD Center of the Asian Institute of Gastroenterology (AIG), IBD’s prevalence has grown substantially, rising from 0.1 per cent in 2006 to over 5 per cent in 2023. The study has also revealed that IBD now accounts for more than 5 per cent of individuals experiencing lower gastrointestinal symptoms, including chronic abdominal pain, changes in bowel habits, and persistent diarrhoea. At present, there is no cure for IBD as such. The focus necessitates the lifelong administration of maintenance drugs. Conventional treatment approaches often lack precision in targeting the exact inflammatory sites and have limited effectiveness. Moreover, these treatments also often pose the risk of severe side effects due to

To read more click on:

Read Previous

The phospholipid advantage is the biggest health differentiator

Read Next

Can AI Help Build a Secure Food System?

Leave a Reply